The fragment based drug discovery platform searches for small molecular "fragments" that bind to the target biological macromolecule. Fragments offer a possibility of exploring much broader chemical combinatorial space that conventional HTS campaigns at a fraction of cost. We use newest NMR equipment to accurately determine weak interactions between fragment and target macromolecule.
600 MHz spectrometer for fragment-based screening; Source: Grzegorz Popowicz
Our facility is able to screen libraries of several thousands of molecules in few days using fully automated sample preparation and measurement system.
Robot for sample preparation; Source: Grzegorz Popowicz

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.